Association of Functional Dyspepsia Symptom Diary Score and Other Scores Related to Functional Dyspepsia and Its Severity

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-11-20

Study Completion Date

2021-06-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Functional dyspepsia (FD) is a common functional gastrointestinal disease. Several patient-reported outcome questionnaires have been established to evaluate the severity of FD, including Dyspepsia Symptom Severity Index (DSSI), Nepean Dyspepsia Index (NDI), and Short-Form Nepean Dyspepsia Index (SF-NDI). Functional Dyspepsia Symptom Diary (FDSD) is a newly symptom-focused patients-reported outcome measure raised by the Patient-Reported Outcome Consortium's Functional Dyspepsia Working Group. The association of the novel FDSD and other scores-related to FD has not been fully investigated. Furthermore, the severity of FD is varied among different patients. It remains unclear how the moderate and severe FD can be defined by the FDSD.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical Course of Functional Dyspepsia and Factors Predicting Outcome in Patients Receiving Medication-based Treatment

NCT05513040

Functional Dyspepsia

RECRUITING

The Clinical Course and Factors for the Progression of Uninvestigated Dyspepsia to Functional Dyspepsia

NCT05823636

Dyspepsia

RECRUITING

The Effect of Multiple Medications on the Incidence of Organic Dyspepsia

NCT05524675

Dyspepsia

UNKNOWN

Correlation Study of Atrophic Gastritis and Dyspepsia Symptoms

NCT07250308

Functional Dyspepsia Chronic Atrophic Gastritis (CAG)

RECRUITING

The Impact of COVID-19 Infection on the Symptoms of Functional Dyspepsia

NCT05749692

Dyspepsia

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Functional Dyspepsia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1\. 18-70 years old
* 2\. Patients who met the Rome IV diagnostic criteria of FD
* 3\. Normal upper endoscopy and abdominal ultrasonography within one year.

Exclusion Criteria

* 1, Patients with local or systemic diseases which may cause dyspeptic symptoms:

1. Known active peptic ulcer, cholecystitis, gallstone, gastrointestinal obstruction, gastroparesis, and etc.
2. Known acute or chronic diseases of liver or kidney
3. Obvious hematological abnormality, or endocrine and metabolic diseases
4. suspected incomplete or complete bowel obstruction
5. Known malignancy
6. Other conditions which may be associated with dyspeptic symptoms (such as NSAIDs associated dyspepsia)
* 2, Pregnancy
* 3, Inability to give informed consent

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No